pyrroles has been researched along with Clostridium Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, C; Yang, M; Yang, Z | 1 |
| Fukuda, S; Iijima, K; Koizumi, S; Matsuhashi, T; Shimodaira, Y; Takahashi, S; Watanabe, K | 1 |
| Gambassi, G; Lapane, KL; Motzkus-Feagans, CA; Pakyz, A; Polk, R | 1 |
3 other study(ies) available for pyrroles and Clostridium Infections
| Article | Year |
|---|---|
Vonoprazan May Induce Clostridium difficile Infection and Nephrotoxicity.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Pyrroles; Sulfonamides | 2023 |
Potent Acid Suppression With Vonoprazan vs Proton Pump Inhibitors Does Not Have Higher Association With Clostridioides difficile Infection.
Topics: Aged; Case-Control Studies; Clostridium Infections; Female; Humans; Japan; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides | 2021 |
Statin use and the risk of Clostridium difficile in academic medical centres.
Topics: Academic Medical Centers; Adult; Age Distribution; Aged; Aged, 80 and over; Atorvastatin; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Confidence Intervals; Cross Infection; Databases, Factual; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Pyrroles; Reference Values; Risk Assessment; Sex Distribution; Simvastatin; United States; Young Adult | 2012 |